DURHAM, NC
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)THE RUTH K BROAD BIOMEDICAL RESEARCH FOUNDATION, founded in 1997, is a small nonprofit that reported $854K in total revenue in fiscal year 2023. Revenue surged 22% from the prior year, signaling strong growth momentum. Expenses of $1.0M exceeded revenue, resulting in a 21% operating deficit.
SUPPORT BASIC SCIENTIFIC RESEARCH, EDUCATION AND DISSEMINATION OF RESEARCH FINDINGS IN THE NEUROSCIENCES.
PROGRAM SERVICE ACCOMPLISHMENTS THE FOUNDATION CONTINUES TO BE COMMITTED TO FUNDING COLLABORATIVE RESEARCH IN NEUROSCIENCES AT DUKE UNIVERSITY SCHOOL OF MEDICINE AS WELL AS AT OTHER ACADEMIC MEDICAL...
PROGRAM SERVICE ACCOMPLISHMENTS THE FOUNDATION CONTINUES TO BE COMMITTED TO FUNDING COLLABORATIVE RESEARCH IN NEUROSCIENCES AT DUKE UNIVERSITY SCHOOL OF MEDICINE AS WELL AS AT OTHER ACADEMIC MEDICAL CENTERS. FUNDED ARE FACULTY PRINCIPAL INVESTIGATORS, POSTDOCTORAL FELLOWS, AND GRADUATE STUDENTS. THE RESEARCH IS CONCERNED WITH FUTHERING THE KNOWLEDGE AVAILABLE ABOUT CAUSES AND POTENTIAL TREATMENTS FOR ALZHEIMER'S DISEASE AND RELATED NEUROLOGICAL DISORDERS. THE FOUNDATION ALSO FUNDS THE RUTH K. BROAD SEMINAR SERIES IN NEUROBIOLOGY AND DISEASE, BRINGING NOTED SCIENTISTS TO DUKE'S CAMPUS THROUGHOUT THE ACADEMIC YEAR TO SHARE RESEARCH FINDINGS, TO PROMOTE NETWORKING AMONG THE SCIENTIFIC COMMUNITY, AND TO MENTOR BUDDING SCIENTISTS. RESULTS OF GRANTS AWARDED BY THE FOUNDATION ARE SHARED THROUGH THIS PROGRAM AS WELL. RESULTS OBTAINED THROUGHOUT THE FUNDING PERIOD FOR THE EXTRAMURAL PRINCIPAL INVESTIGATOR GRANT FURTHER DEFINED THE MOLECULAR INTERACTIONS BETWEEN THE GENE APOE4 AND THE ALZHEIMER'S DISEASE FACTOR AB. THESE EXPERIMENTS MAY PROVIDE MECHANISTIC INSIGHTS INTO THE ROLE OF APOE4 AS A RISK FACTOR FOR THE DEVELOPMENT OF ALZHEIMER'S DISEASE.
IN FY19, THE BOARD OF THE RUTH K. BROAD FOUNDATION APPROVED A NEW AWARD, THE ANN B. BUSSEL AWARD. THE FOUNDATION WILL BE AWARDING A TWO-YEAR GRANT, EFFECTIVE JULY 1, 2020 FOR $100,000 EACH YEAR. THE...
IN FY19, THE BOARD OF THE RUTH K. BROAD FOUNDATION APPROVED A NEW AWARD, THE ANN B. BUSSEL AWARD. THE FOUNDATION WILL BE AWARDING A TWO-YEAR GRANT, EFFECTIVE JULY 1, 2020 FOR $100,000 EACH YEAR. THE FIRST AWARD PERIOD BEGAN JULY 1, 2020. THE PURPOSE OF THIS AWARD IS TO IMPROVE OUR UNDERSTANDING OF, AND ABILITY TO TREAT, ALZHEIMER'S DISEASE AND PREFERENCE IS FOR RESEARCH APPROACHES THAT STUDY HUMANS TO COMPLEMENT THE RUTH K. BROAD FOUNDATION'S EXISTING, PRIMARY BASIC NEUROSCIENCE, RESEARCH GRANT PROGRAMS. THE GRANT WILL BE AWARDED TO FACULTY AT DUKE. THE FACULTY MEMBER HAS A COLLABORATOR AT ANOTHER INSTITUTION, SPLITTING THE GRANT TO CO-FUND THE INVESTIGATORS AT THE TWO INSTITUTIONS WILL BE CONSIDERED.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $854,406 | $698,047 | +0.2% |
| Expenses | $1,037,317 | $568,108 | +0.8% |
| Net Income | $-182,911 | $129,939 | -2.4% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| STEPHEN G LISBERGER | DIRECTOR | 0.10 |
Director
|
$0 | $40,376 | $505,267 |
| RICHARD J O'BRIEN MD | DIRECTOR | 0.10 |
Director
|
$0 | $47,144 | $564,052 |
| JAMES MCNAMARA MD | DIRECTOR | 0.10 |
Director
|
$0 | $53,428 | $369,267 |
| COLIN DUCKETT | DIRECTOR | 0.10 |
Director
|
$0 | $47,369 | $449,804 |
| MICHAEL SHOLTZ JD | DIRECTOR | 0.10 |
Director
|
$0 | $64,357 | $338,780 |
| GEETA SWAMY MD | DIRECTOR/PART YEAR CHAIRMAN | 0.10 |
Officer
Director
|
$0 | $60,044 | $575,877 |
| KAREN B BERMAN | DIRECTOR | 0.10 |
Director
|
$0 | $0 | $0 |
| DANIEL J BUSSEL | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| DEBORAH BUSSEL | DIRECTOR/VICE PRESIDENT | 0.50 |
Officer
Director
|
$0 | $0 | $0 |
| JOHN M BUSSEL | DIRECTOR/TREASURER | 0.10 |
Officer
Director
|
$0 | $0 | $0 |
| MOIRA RYNN MD | DIRECTOR | 0.10 |
Director
|
$0 | $59,495 | $646,710 |
| CURTIS ALAN LOCKSHIN | DIRECTOR | 0.10 |
Director
|
$0 | $0 | $0 |
| MANUEL F UTSET MD | DIRECTOR | 0.10 |
Director
|
$0 | $0 | $0 |
| HANNAH MOSHONTZ DE LA ROCHA | DIRECTOR | 0.10 |
Director
|
$0 | $0 | $0 |
| HEATHER WHITSON MD | DIRECTOR | 0.10 |
Director
|
$0 | $51,470 | $366,462 |
| RALPH SNYDERMAN MD | DIRECTOR/PART YEAR CHAIRMAN | 0.10 |
Officer
Director
|
$0 | $68,895 | $1,466,357 |
| CATHLEEN DURGIN | SECRETARY | 2.00 |
Officer
|
$0 | $19,381 | $103,036 |
| ERICA KITCHEN | PRESIDENT/EXECUTIVE DIRECTOR | 2.00 |
Officer
|
$0 | $31,612 | $126,504 |
| JENNIFER GALLINA | FORMER OFFICER | 0.10 |
|
$0 | $10,771 | $283,805 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | No data | No data | No data | No data |
| 2024 | $854,406 | $1,037,317 | $17,985,119 | $-182,911 |
| 2023 | $698,047 | $568,108 | $17,816,997 | $129,939 |
| 2022 | $648,234 | $531,504 | $18,625,123 | $116,730 |
| 2021 | $586,039 | $520,826 | $19,461,345 | $65,213 |
| 2020 | $532,076 | $428,794 | $13,114,830 | $103,282 |
| 2019 | $534,960 | $522,106 | $13,505,405 | $12,854 |
Compare THE RUTH K BROAD BIOMEDICAL RESEARCH FOUNDATION with other nonprofits in North Carolina and across the country.